2017 Archived Content
As biologics gain greater prominence, protein engineers adjust their foci to new indications, improved targeting, new formats, and products that are truly differentiated relative to competitors. The Protein Engineering & Development pipeline offers a weeklong exploration of state-of-the-art approaches for developing safe and effective protein and antibody-based therapeutics, including improving qualities, enhancing efficacy, and fine-tuning manufacturing.
Recombinant Protein Therapeutics
Enhancing Antibody Binding and Specificity
Emerging Technologies for Antibody Discovery